Delivery Order SPE2DB25D3020-SPE2DB25FWHRL
Award Date
5/22/25
Potential Completion Date
5/23/25
Potential Value
$10K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,977.03 firm fixed-price contract is for the delivery of 4,567,875,611 units of the prescription medication Ondansetron HCL 4 mg tablet. The contract has an ultimate completion date of April 11, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,765.54 contract is for the supply of 4,568,178,374 tablets of the prescription medication Ondansetron HCL 4 mg, with a performance period through May 9, 2025. This delivery order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,158.00, is for the delivery of 4,568,013,655 units of Ondansetron HCL 4 mg tablets. The contract is a firm fixed-price, non-set-aside award with a performance period through April 24, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,282,803 units of the prescription medication Ondansetron ODT 4 mg Tablet (30s). The contract has a ceiling value of $7,703.86 and is a firm fixed price delivery order with a period of performance through July 30, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is not designated as a set-aside contract....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,239,126 units of the prescription medication Ondansetron ODT 4 mg Tablet in 30-count packages. The contract has a ceiling value of $9,363.22 and a completion date of May 14, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,823,887 units of Ondansetron HCL 4 mg tablets in packages of 500 for a ceiling value of $9,840.92. The contract is a firm fixed-price, delivery order contract with an ultimate completion date of April 8, 2025. The contract does not have a set-aside designation,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,093 units of the prescription medication Ondansetron HCL 4 mg tablet. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $1,606.01 and a period of performance through May 1, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,285,896 units of the prescription medication Ondansetron ODT 4 MG Tablet 30S. The contract has a ceiling value of $12,829.35 and is a firm fixed-price delivery order with an ultimate completion date of July 30, 2024. This contract is not designated as a set-aside. Amerisourcebergen,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,206,756 units of the medication Ondansetron ODT 4 mg tablet in quantities of 30 per package. The contract has a ceiling value of $13,890.74 and is a firm fixed-price delivery order, with a period of performance through May 12, 2025. The contract is not designated as a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,116.51 contract is for the supply of 4,559,438,684 units of Ondansetron HCL 4 mg tablets. The contract has a period of performance through December 22, 2022 and was awarded on December 21, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...